Delivery Order SPE2DB25D3201-SPE2DB25FNTBM
Award Date
5/9/25
Potential Completion Date
5/12/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,023.95, is for the supply of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance through January 22, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 5-320 MG TABLET 30S, a cardiovascular medication, with a ceiling value of $3,251.71 and a period of performance through March 2024. The contract was awarded on an unrestricted basis, with no set-aside designation. It is part of a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,840.67 contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of March 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EXFORGE 10-160 MG TABLET 30S. The firm fixed price contract has a ceiling value of $1,200.60 and an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,089.05 contract is for the provision of 4563783806 EXFORGE 5-320 MG TABLET 30S, a pharmaceutical product, with a completion date of February 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of EXFORGE HCT 10-320-25 MG TAB 30S, a prescription medication. The contract has a ceiling value of $3,780.26 and runs through October 16, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, will be responsible for providing the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of EXFORGE 5-160 MG TABLET 30S, a prescription pharmaceutical product. The firm fixed price award, valued at $7,090.57, has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor, and this award is associated with a larger indefinite delivery contract (IDC) awarded by DLA with a potential...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of EXFORGE 10-320 MG TABLET 30S. The award has a ceiling value of $2,048.86 and a period of performance ending on September 23, 2024. This contract is not set-aside. Amerisourcebergen is a large pharmaceutical distributor that holds various Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,092.89, is for the supply of 4568185974 - EXFORGE 10-160 MG TABLET 30S, a medication used to treat high blood pressure. The award is a firm-fixed price contract with a period of performance through May 9, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,817.75 firm fixed price contract is for the delivery of EXFORGE 10-160 MG TABLET 30S, a brand name pharmaceutical product. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which...